Foster Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Sell
15,893
-6,702
-30% -$90.4K 0.01% 287
2026
Q1
$313K Buy
22,595
+5,892
+35% +$82K 0.01% 209
2025
Q4
$235K Sell
16,703
-7,405
-31% -$104K 0.01% 256
2025
Q3
$337K Buy
24,108
+1,435
+6% +$20.6K 0.01% 189
2025
Q2
$341K Buy
22,673
+7,835
+53% +$112K 0.01% 175
2025
Q1
$196K Buy
14,838
+1,134
+8% +$15.6K 0.01% 216
2024
Q4
$216K Buy
+13,704
New +$206K 0.01% 183

Other funds holding RDY

Foster Group's RDY Position: Q2 2026 in Review

Foster Group reduced its Dr. Reddy's Laboratories (RDY) stake by 30% in Q2 2026, selling an estimated $90.4K and leaving 15,893 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #287.

Foster Group first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $341K in Q2 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Foster Group held 15,893 shares of Dr. Reddy's Laboratories worth $230K as of Q2 2026.
  • Foster Group sold 6,702 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $90.4K.
  • Dr. Reddy's Laboratories made up 0.01% of Foster Group's portfolio in Q2 2026, its #287 holding.
  • Foster Group first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Foster Group's Dr. Reddy's Laboratories position peaked at $341K in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.